Ro

Series CHealthcare Technologyprivate

Direct-to-patient healthcare platform offering telemedicine, diagnostics, and pharmacy for chronic conditions.

Valuation
$5B
Total Funding
$876M
Stage
Series C
Sector
Healthcare Technology
Headquarters
New York, NY
CEO
Zachariah Reitano
IPO Status
private

Funding History

Round Amount Date
Series C $500M Mar 2021
Series B $200M Mar 2020
Series A $88M Oct 2018
Seed $3M Oct 2017

Track Ro IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO โ€” the pre-IPO intelligence platform.

Loading company data...